Pharmacokinetics of cyclophosphamide enantiomers in patients with breast cancer (2011)
Fonte: Cancer Chemotherapy and Pharmacology. Unidades: FCFRP, FMRP
Assuntos: NEOPLASIAS MAMÁRIAS, FARMACOCINÉTICA, ANTINEOPLÁSICOS
ABNT
FERNANDES, Bruno José Dumêt et al. Pharmacokinetics of cyclophosphamide enantiomers in patients with breast cancer. Cancer Chemotherapy and Pharmacology, v. 68, n. 4, p. 897-904, 2011Tradução . . Disponível em: https://doi.org/10.1007/s00280-011-1554-7. Acesso em: 22 ago. 2024.APA
Fernandes, B. J. D., Silva, C. de M., Andrade, J. M., Matthes, Â. do C. S., Coelho, E. B., & Lanchote, V. L. (2011). Pharmacokinetics of cyclophosphamide enantiomers in patients with breast cancer. Cancer Chemotherapy and Pharmacology, 68( 4), 897-904. doi:10.1007/s00280-011-1554-7NLM
Fernandes BJD, Silva C de M, Andrade JM, Matthes  do CS, Coelho EB, Lanchote VL. Pharmacokinetics of cyclophosphamide enantiomers in patients with breast cancer [Internet]. Cancer Chemotherapy and Pharmacology. 2011 ; 68( 4): 897-904.[citado 2024 ago. 22 ] Available from: https://doi.org/10.1007/s00280-011-1554-7Vancouver
Fernandes BJD, Silva C de M, Andrade JM, Matthes  do CS, Coelho EB, Lanchote VL. Pharmacokinetics of cyclophosphamide enantiomers in patients with breast cancer [Internet]. Cancer Chemotherapy and Pharmacology. 2011 ; 68( 4): 897-904.[citado 2024 ago. 22 ] Available from: https://doi.org/10.1007/s00280-011-1554-7